Review Article

In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine

Table 3

Clinical studies that used direct radiopharmaceutical labeling for cell therapies in cardiology.

Study referenceRadiopharmaceuticalType of lesionCell typeRouteNumber of patientsNumber of cells injectedImaging time points

Hofmann et al., 2005 [72]18F-FDGAcute myocardial infarctionBM-MNCs
Intracoronary
Intravenous
12Not specified75 min
Blocklet et al., 2006 [71]18F-FDG
111In-oxine
Acute myocardial infarctionPB-MNCsIntracoronary62–4 × 1061 hour (18F-FDG)
19 and 43 hours (111In-oxine)
Kang et al., 2006 [73]18F-FDGAcute or nonacute myocardial infarctionPB-MNCsIntracoronary
Intravenous
20Not specified2, 4, and 20 hours
Goussetis et al., 2006 [74]Tc-HMPAOChronic ischemic cardiomyopathyBM-MNCs Intracoronary 80.8 × 1071 and 24 hours
Caveliers et al., 2007 [66]111In-oxineChronic ischemic cardiomyopathyPB-MNCs Intracoronary85–35 × 1062 and 12 hours
Penicka et al., 2007 [75]Tc-HMPAOAcute or nonacute myocardial infarctionBM-MNCsIntracoronary 1024.2–57.0 × 1082 and 20 hours
Kurpisz et al., 2007 [67]111In-oxineAcute myocardial infarctionBM-MNCsIntracoronary32–4 × 10624 hours
Schots et al., 2007 [68]111In-oxineNonacute myocardial infarctionPB-MNCsIntracoronary 85–10 × 106
18–50 × 106
2 and 12 hours
Schächinger et al., 2008 [69]111In-oxineAcute or nonacute myocardial infarctionPB-MNCsIntracoronary 2015 × 1061 and 24 hours
Dedobbeleer et al., 2009 [70]18F-FDGNonacute myocardial infarctionPB-MNCsIntracoronary 71.8 × 1071 hour
Silva et al., 2009 [76]; Moreira et al., 2011 [77]Tc-HMPAOAcute myocardial infarctionBM-MNCsIntracoronary
IRCV
301 × 1074 and 24 hours
Musialek et al., 2011 [78]Tc-HMPAOAcute myocardial infarctionBM-MNCsIntracoronary340.92–7.54 × 1061 hour
Barbosa da Fonseca et al., 2011 [80]TcChronic chagasic cardiomyopathyBM-MNCsIntracoronary64.4 × 1081, 3, and 24 hours
Kollaros et al., 2012 [81]Tc-HMPAOChronic myocardial infarctionBM-MNCsIntracoronary13Not specified1 hour
Musialek et al., 2013 [79]Tc-HMPAORecent myocardial infarctionBM-MNCsIntracoronary314.3 × 1061 hour
Vrtovec et al., 2013 [82]Tc-HMPAONonischemic dilated cardiomyopathyBM-MNCsIntracoronary transendocardial401 × 10618 hours
Haddad et al., 2015 [83]Tc-HMPAONonischemic dilated cardiomyopathyPB-MNCsTransendocardial3775 × 1062 and 18 hours

111In: indium-111; 18F: fluorine-18; Tc: technetium-99m; BM-MNCs: bone marrow mononuclear cells; FDG: fluorodeoxyglucose; HMPAO: hexamethylpropyleneamine oxime; IRCV: interstitial retrograde coronary venous; PB-MNCs: peripheral blood mononuclear cells.